Genetic manipulation of Hif-1α during mycobacterial infection has not previously been explored, and further understanding of the roles of this critical host-signaling pathway may uncover Hif and its signaling components as future therapeutic targets for intervention against TB. This evidence concerns the gene HIF1A and tuberculosis.